576 related articles for article (PubMed ID: 17307438)
1. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor Egr-1 in calcific aortic valve disease.
Ghazvini-Boroujerdi M; Clark J; Narula N; Palmatory E; Connolly JM; DeFelice S; Xu J; Jian B; Hazelwood S; Levy RJ
J Heart Valve Dis; 2004 Nov; 13(6):894-903. PubMed ID: 15597579
[TBL] [Abstract][Full Text] [Related]
3. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis.
Jian B; Narula N; Li QY; Mohler ER; Levy RJ
Ann Thorac Surg; 2003 Feb; 75(2):457-65; discussion 465-6. PubMed ID: 12607654
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway.
Yu Z; Seya K; Daitoku K; Motomura S; Fukuda I; Furukawa K
J Pharmacol Exp Ther; 2011 Apr; 337(1):16-23. PubMed ID: 21205918
[TBL] [Abstract][Full Text] [Related]
5. Role of human valve interstitial cells in valve calcification and their response to atorvastatin.
Osman L; Yacoub MH; Latif N; Amrani M; Chester AH
Circulation; 2006 Jul; 114(1 Suppl):I547-52. PubMed ID: 16820635
[TBL] [Abstract][Full Text] [Related]
6. Release of leukotriene B4, transforming growth factor-beta1 and microparticles in relation to aortic valve calcification.
Kochtebane N; Passefort S; Choqueux C; Ainoun F; Achour L; Michel JB; Bäck M; Jacob MP
J Heart Valve Dis; 2013 Nov; 22(6):782-8. PubMed ID: 24597398
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2.
Yang X; Meng X; Su X; Mauchley DC; Ao L; Cleveland JC; Fullerton DA
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):1008-15. PubMed ID: 19664780
[TBL] [Abstract][Full Text] [Related]
9. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2.
Yang X; Fullerton DA; Su X; Ao L; Cleveland JC; Meng X
J Am Coll Cardiol; 2009 Feb; 53(6):491-500. PubMed ID: 19195606
[TBL] [Abstract][Full Text] [Related]
10. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions.
Borrelli V; di Marzo L; Sapienza P; Colasanti M; Moroni E; Cavallaro A
Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609
[TBL] [Abstract][Full Text] [Related]
11. Influence of receptor activator of nuclear factor kappa B on human aortic valve myofibroblasts.
Kaden JJ; Dempfle CE; Kiliç R; Sarikoç A; Hagl S; Lang S; Brueckmann M; Borggrefe M
Exp Mol Pathol; 2005 Feb; 78(1):36-40. PubMed ID: 15596058
[TBL] [Abstract][Full Text] [Related]
12. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
Kaden JJ; Vocke DC; Fischer CS; Grobholz R; Brueckmann M; Vahl CF; Hagl S; Haase KK; Dempfle CE; Borggrefe M
Z Kardiol; 2004 Feb; 93(2):124-30. PubMed ID: 14963678
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calcifying nodule formation in cultured porcine aortic valve cells by nitric oxide donors.
Kennedy JA; Hua X; Mishra K; Murphy GA; Rosenkranz AC; Horowitz JD
Eur J Pharmacol; 2009 Jan; 602(1):28-35. PubMed ID: 19056377
[TBL] [Abstract][Full Text] [Related]
14. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix.
Yip CY; Chen JH; Zhao R; Simmons CA
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):936-42. PubMed ID: 19304575
[TBL] [Abstract][Full Text] [Related]
15. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
Kaden JJ; Bickelhaupt S; Grobholz R; Vahl CF; Hagl S; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
J Heart Valve Dis; 2004 Jul; 13(4):560-6. PubMed ID: 15311861
[TBL] [Abstract][Full Text] [Related]
16. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves.
Helske S; Syväranta S; Kupari M; Lappalainen J; Laine M; Lommi J; Turto H; Mäyränpää M; Werkkala K; Kovanen PT; Lindstedt KA
Eur Heart J; 2006 Jun; 27(12):1495-504. PubMed ID: 16401677
[TBL] [Abstract][Full Text] [Related]
17. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein].
Huang HC; Liu SY; Liang Y; Liu Y; Li JZ; Wang HY
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):328-31. PubMed ID: 15854510
[TBL] [Abstract][Full Text] [Related]
18. miRNA-141 is a novel regulator of BMP-2-mediated calcification in aortic stenosis.
Yanagawa B; Lovren F; Pan Y; Garg V; Quan A; Tang G; Singh KK; Shukla PC; Kalra NP; Peterson MD; Verma S
J Thorac Cardiovasc Surg; 2012 Jul; 144(1):256-62. PubMed ID: 22336757
[TBL] [Abstract][Full Text] [Related]
19. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
[TBL] [Abstract][Full Text] [Related]
20. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
Fujiwara M; Muragaki Y; Ooshima A
Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
